Company Profile (AI Text)
Name: Rubitection
Canonical URL: https://wefunder.com/rubitection
Updated at: 2026-06-19T05:00:58Z

Tagline:  AI Care Management System for Chronic Deadly Wounds (diabetic foot ulcers and bedsores) 

Key claims:
- Total raised on Wefunder: 108800 | citation: https://wefunder.com/rubitection#claim-total-raised
- Total investors: 48 | citation: https://wefunder.com/rubitection#claim-total-investors

Verified facts:
- Total raised on Wefunder: 108800 | observed_at: 2026-06-19T05:00:58Z | expires_at: 2026-06-20T05:00:58Z
- Total investors: 48 | observed_at: 2026-06-19T05:00:58Z | expires_at: 2026-06-20T05:00:58Z

Computed metrics:
- total_amount_raised: 108800
- total_investors: 48
- team_size: 2
- featured_investor_count: 1
- faq_count: 3
- recent_post_count: 0

Quick facts:
- $26 billion total market that is growing to address the aging population | citation: https://wefunder.com/rubitection#claim-fact-1
- Investor backed including AARP Agetech collaborative totaling $800K to date | citation: https://wefunder.com/rubitection#claim-fact-2
- Won several awards including AARP Agetech, Boston Scientific Connected Patient, and She Loves Tech | citation: https://wefunder.com/rubitection#claim-fact-3
- Have a pipeline of clinical partners including Baylor School of Medicine | citation: https://wefunder.com/rubitection#claim-fact-4
- Improves care and addresses a health disparity for people of color | citation: https://wefunder.com/rubitection#claim-fact-5
- Built a functional prototype and collected initial positive patient data | citation: https://wefunder.com/rubitection#claim-fact-6
- We have interest from 5 corporate partners | citation: https://wefunder.com/rubitection#claim-fact-7
- Two issued patents which protect our $26 billion market | citation: https://wefunder.com/rubitection#claim-fact-8

FAQ:
- Q: Hi Rubitection Team! I'm Zac from D3VC, a venture fund specializing in equity crowdfunding deals, and we have a few questions to understand the opportunity better. Could you explain how the early detection system works and its impact on treatment and outcomes? Have commercial ...
  A: Hello Zac, Great to hear from you. Thanks for your interest. Sorry for the delayed response. I have itemized your questions and the answers below. There is also some information in Rubitection's deck on Wefunder that can also provide additional insights into your questions. If you have additional questions let me know and I can setup a meeting or webinar. 1. Could you explain how the early detection system works and its impact on treatment and outcomes? - [How it works] We use a combination o...
- Q: Thanks for your thorough responses, Sanna. We appreciate the additional context. A few follow-ups—could you clarify the source of the $300K raised on the same terms? Additionally, will the funds from this round be sufficient to secure FDA certification, or do you anticipate re...
  A: Hello Zac, Thanks again for the follow up questions. I have itemized your questions and the answers below. 1. Source of the $300K - An accelerator and other private investors. 2. Funds sufficient for FDA certification and additional funds needed - No. Our current funding round supports the first phase of FDA engagement. We will then raise $10M -$15M to fund the second phase to complete FDA and launch the product. 3. Automated insights or physician interpretation - yes because if you can make ...
- Q: Hello, congrats on your success to date. I like the concept and business model. My questions is the timeline in the video seems outdated. it says the 2023 milestones are prototypes/pilots, 2024 milestones are product dev and FDA approval, 2025 milestones are launch and sales. ...
  A: Hello LD, Thanks for the support and follow up questions. I have itemized them below. 1) Updated timeline: We are focused on pilots in 2025. The timeline is adjusted based on available funding to complete the milestones. 2) Pipeline into facilities for sales or hiring someone: We are currently recruiting sites for Beta testing/sales. We will hire a sales team and secure sales partnerships to target the boarder market.